Reuters logo
BRIEF-Anthera announces the phase 3 solution study with Sollpura
December 27, 2016 / 9:18 PM / 9 months ago

BRIEF-Anthera announces the phase 3 solution study with Sollpura

Dec 27 (Reuters) - Anthera Pharmaceuticals Inc

* Anthera announces the Phase 3 solution study with Sollpura in cystic fibrosis patients with exocrine pancreatic insufficiency demonstrates encouraging results - additional study needed Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below